BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17251181)

  • 1. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
    Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
    J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
    Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
    J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
    Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
    PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptors that mediate the direct lethality of anthrax toxin.
    Liu S; Zhang Y; Hoover B; Leppla SH
    Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
    Scobie HM; Rainey GJ; Bradley KA; Young JA
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-specific requirements for anthrax toxin delivery into cells.
    Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interaction between anthrax toxin and its cellular receptors.
    Liu S; Leung HJ; Leppla SH
    Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
    Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
    Martchenko M; Jeong SY; Cohen SN
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of anthrax toxin is influenced by receptor expression.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Sep; 15(9):1330-6. PubMed ID: 18596206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
    Liu S; Leppla SH
    J Biol Chem; 2003 Feb; 278(7):5227-34. PubMed ID: 12468536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective antigen component of anthrax toxin forms functional octameric complexes.
    Kintzer AF; Thoren KL; Sterling HJ; Dong KC; Feld GK; Tang II; Zhang TT; Williams ER; Berger JM; Krantz BA
    J Mol Biol; 2009 Sep; 392(3):614-29. PubMed ID: 19627991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing the receptor specificity of anthrax toxin.
    Mechaly A; McCluskey AJ; Collier RJ
    mBio; 2012; 3(3):. PubMed ID: 22550037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
    Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted silencing of anthrax toxin receptors protects against anthrax toxins.
    Arévalo MT; Navarro A; Arico CD; Li J; Alkhatib O; Chen S; Diaz-Arévalo D; Zeng M
    J Biol Chem; 2014 May; 289(22):15730-8. PubMed ID: 24742682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
    Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
    PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.
    Hu H; Leppla SH
    PLoS One; 2009 Nov; 4(11):e7946. PubMed ID: 19956758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-cell voltage clamp measurements of anthrax toxin pore current.
    Wolfe JT; Krantz BA; Rainey GJ; Young JA; Collier RJ
    J Biol Chem; 2005 Nov; 280(47):39417-22. PubMed ID: 16183642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects from metal ion in tumor endothelial marker 8 and anthrax protective antigen: BioLayer Interferometry experiment and molecular dynamics simulation study.
    Jia Z; Ackroyd C; Han T; Agrawal V; Liu Y; Christensen K; Dominy B
    J Comput Chem; 2017 Jun; 38(15):1183-1190. PubMed ID: 28437008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.